Literature DB >> 9657377

The carboxy-terminal domain of the receptor-associated protein binds to the Vps10p domain of sortilin.

J Tauris1, L Ellgaard, C Jacobsen, M S Nielsen, P Madsen, H C Thøgersen, J Gliemann, C M Petersen, S K Moestrup.   

Abstract

Binding of the receptor-associated protein (RAP) to the newly identified putative sorting receptor, sortilin, was analyzed by surface plasmon resonance analysis of recombinant RAP and sortilin domains and compared with binding to megalin and low density lipoprotein receptor-related protein (LRP). The data show that the RAP-binding site in sortilin is localized in the cysteine-rich lumenal part homologous to yeast vacuolar protein-sorting 10 protein (Vps10p), and the sortilin-binding site in RAP is localized in the carboxy-terminal domain III of the three homologous domains in RAP. Whereas sortilin bound only RAP domain III, megalin and LRP bound all RAP domains with the functional affinity order: domain III >domain I > domain II.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9657377     DOI: 10.1016/s0014-5793(98)00559-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

Review 1.  The role of neurotensin in central nervous system pathophysiology: what is the evidence?

Authors:  Fannie St-Gelais; Claudia Jomphe; Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2006-07       Impact factor: 6.186

Review 2.  Sortilin, encoded by the cardiovascular risk gene SORT1, and its suggested functions in cardiovascular disease.

Authors:  Mads Kjolby; Morten Schallburg Nielsen; Claus Munck Petersen
Journal:  Curr Atheroscler Rep       Date:  2015-04       Impact factor: 5.113

3.  Identification of a linear epitope in sortilin that partakes in pro-neurotrophin binding.

Authors:  Olga Serup Andersen; Prisca Boisguerin; Simon Glerup; Sune Skeldal; Rudolf Volkmer; Thomas E Willnow; Anders Nykjaer; Olav M Andersen
Journal:  J Biol Chem       Date:  2010-02-16       Impact factor: 5.157

4.  Propeptide cleavage conditions sortilin/neurotensin receptor-3 for ligand binding.

Authors:  C Munck Petersen; M S Nielsen; C Jacobsen; J Tauris; L Jacobsen; J Gliemann; S K Moestrup; P Madsen
Journal:  EMBO J       Date:  1999-02-01       Impact factor: 11.598

5.  Structural and functional analysis of APOA5 mutations identified in patients with severe hypertriglyceridemia.

Authors:  Elena Mendoza-Barberá; Josep Julve; Stefan K Nilsson; Aivar Lookene; Jesús M Martín-Campos; Rosa Roig; Alfonso M Lechuga-Sancho; John H Sloan; Pablo Fuentes-Prior; Francisco Blanco-Vaca
Journal:  J Lipid Res       Date:  2013-01-10       Impact factor: 5.922

6.  Receptor-mediated endocytosis of α-galactosidase A in human podocytes in Fabry disease.

Authors:  Thaneas Prabakaran; Rikke Nielsen; Jakob V Larsen; Søren S Sørensen; Ulla Feldt-Rasmussen; Moin A Saleem; Claus M Petersen; Pierre J Verroust; Erik I Christensen
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

7.  Mannose 6-phosphate receptor and sortilin mediated endocytosis of α-galactosidase A in kidney endothelial cells.

Authors:  Thaneas Prabakaran; Rikke Nielsen; Simon C Satchell; Peter W Mathieson; Ulla Feldt-Rasmussen; Søren S Sørensen; Erik I Christensen
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

8.  Impaired prosaposin lysosomal trafficking in frontotemporal lobar degeneration due to progranulin mutations.

Authors:  Xiaolai Zhou; Lirong Sun; Oliver Bracko; Ji Whae Choi; Yan Jia; Alissa L Nana; Owen Adam Brady; Jean C Cruz Hernandez; Nozomi Nishimura; William W Seeley; Fenghua Hu
Journal:  Nat Commun       Date:  2017-05-25       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.